Earnings Review and Free Research Report: Aehr Reported Better Than Expected Revenue

LONDON, UK / ACCESSWIRE / October 11, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Aehr Test Systems (NASDAQ: AEHR) ("Aehr"), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=AEHR, following the Company's posting of its financial results on September 28, 2017, for the first quarter of the fiscal year 2018. The supplier of semiconductor test and burn-in equipment's net revenue increased 31% on a y-o-y basis. Our daily stock reports are accessible for free, and with those to look forward today you also will be signing up for a complimentary member's account at:

http://protraderdaily.com/register/

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on AEHR. With the links below you can directly download the report of your stock of interest free of charge at:

http://protraderdaily.com/optin/?symbol=AEHR

Earnings Reviewed

For the three months ended August 31, 2017, Aehr's net revenue increased 31% to $6.97 million from $5.32 million in Q1 FY17. The net revenue figures surpassed analysts' expectations of $6.75 million.

During Q1 FY18, the Company's gross profit increased 32.1% to $2.92 million from $2.21 million in Q1 FY17. For the reported quarter, the Company's gross margin increased 30 basis points to 41.8% of revenue from 41.5% of revenue in Q1 FY17.

During Q1 FY18, Aehr's selling, general, and administrative expenses (SG&A) increased 4% to $1.79 million from $1.72 million in Q1 FY17. During Q1 FY18, the Company's R&D expenses decreased 9.9% to $955,000 from $1.06 million in the same period of last year. For the reported quarter, the Company's total operating expenses decreased 1% to $2.75 million from $2.78 million in Q1 FY17.

For the reported quarter, the Company's operating income was $172,000 compared to an operating loss of $570,000 in Q1 FY17.

During Q1 FY18, Aehr's net income was $10,000 compared to a net loss of $755,000 in Q1 FY17. For the reported quarter, the Company's adjusted net income was $226,000 compared to an adjusted net loss of $436,000 in Q1 FY17. During Q1 FY18, Aehr's diluted earnings per share (EPS) was $0.00 compared to a negative diluted EPS of $0.06 in Q1 FY17. For the reported quarter, the Company's adjusted diluted EPS was positive $0.01 compared to a negative adjusted diluted EPS of $0.03 in Q1 FY17.

Order Update

During Q1 FY18, Aehr received a follow-on order exceeding $1.3 million for multiple WaferPak™ contractors for its FOX-1 wafer level test systems for flash memory testing.

During Q1 FY18, the Company received a follow-on order exceeding $3.8 million for multiple ABTS test and burn-in systems from a leading multi-national manufacturer of advanced logic integrated circuits (ICs) for automotive devices.

During August 2017, Aehr announced first volume production order exceeding $3.0 million for multiple Advanced Burn-in and Test System (ABTS™) thermal chambers from an OEM customer for a high-volume application.

On September 28, 2017, the Company announced that it received follow-on orders totaling $2.7 million from a subcontractor of its initial lead FOX-XPTM Test and Burn-in System customer.

During September 2017, Aehr also received a $900,000 order from its second lead FOX-XP customer to provide additional testing capability and power handling capacity to test and burn-in new silicon photonics.

Balance Sheet

As on August 31, 2017, Aehr's cash and cash equivalents decreased 21.4% to $13.99 million from $17.80 million in Q4 FY17.

During Q1 FY18, the Company's net accounts receivables increased 50.8% to $6.05 million from $4.01 million in Q4 FY17.

For the reported quarter, Aehr's inventories increased 36.6% to $9.02 million from $6.60 million in Q4 FY17.

For the reported quarter, the Company's accounts payable increased 23.4% to $3.47 million from $2.81 million in Q4 FY17.

During Q1 FY18, Aehr's long-term debt was at par with the $6.11 million reported in Q4 FY17.

Stock Performance

On Tuesday, October 10, 2017, the stock closed the trading session at $3.68, slipping 1.08% from its previous closing price of $3.72. A total volume of 77.02 thousand shares have exchanged hands. Aehr Test Systems' stock price surged 11.52% in the last one month and 26.46% in the previous twelve months. Furthermore, since the start of the year, shares of the Company have skyrocketed 52.70%. The stock currently has a market cap of $78.64 million.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily